三例侵袭性B细胞非霍奇金淋巴瘤患者在接受利妥昔单抗联合CHOP-14进行一线治疗期间发生了耶氏肺孢子菌肺炎（PCP）。 - Suppr

Suppr

超能文献

Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma.

作者信息

Venhuizen Annemarie C, Hustinx Willem N M, van Houte Arend-Jan, Veth Gerda, van der Griend René

出版信息

Eur J Haematol. 2008 Mar;80(3):275-6. doi: 10.1111/j.1600-0609.2007.00994.x. Epub 2007 Nov 15.

DOI:10.1111/j.1600-0609.2007.00994.x

PMID:18005387

Abstract

摘要

相似文献

Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma.三例侵袭性B细胞非霍奇金淋巴瘤患者在接受利妥昔单抗联合CHOP-14进行一线治疗期间发生了耶氏肺孢子菌肺炎（PCP）。

Eur J Haematol. 2008 Mar;80(3):275-6. doi: 10.1111/j.1600-0609.2007.00994.x. Epub 2007 Nov 15.

The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis.在接受利妥昔单抗、环磷酰胺、非聚乙二醇化脂质体阿霉素、长春新碱和泼尼松龙剂量密集疗法并进行充分的耶氏肺孢子菌肺炎预防的患者中，耶氏肺孢子菌肺炎的发病率并不更高。

Leuk Lymphoma. 2011 Jan;52(1):148-9. doi: 10.3109/10428194.2010.525726. Epub 2010 Nov 11.

Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab.两例在含利妥昔单抗的CHOP方案化疗后发生耶氏肺孢子菌肺炎合并非霍奇金淋巴瘤的病例。

J Clin Exp Hematop. 2010;50(2):159-62. doi: 10.3960/jslrt.50.159.

The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.利妥昔单抗-CHOP-14 方案治疗患者中肺孢子菌肺炎风险增加可通过应用复方磺胺甲噁唑预防：单中心经验。

Acta Haematol. 2012;127(2):110-4. doi: 10.1159/000334113. Epub 2011 Dec 16.

[Rash, fever, eosinophilia and elevated liver enzymes. DRESS syndrome (drug reaction or rash with eosinophilia and systemic symptoms)].皮疹、发热、嗜酸性粒细胞增多及肝酶升高。药物超敏反应伴嗜酸性粒细胞增多和全身症状综合征（DRESS综合征）

Praxis (Bern 1994). 2010 Jun 23;99(13):767-77; quiz 776. doi: 10.1024/1661-8157/a000199.

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.接受利妥昔单抗-CHOEP-14方案治疗的B细胞淋巴瘤患者中的耶氏肺孢子菌肺炎

Haematologica. 2007 Jan;92(1):139-40. doi: 10.3324/haematol.10564.

A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen?接受R-CHOP-14治疗的侵袭性淋巴瘤中肺孢子菌感染的复发：剂量密集方案的代价？

Leuk Lymphoma. 2010 May;51(5):737-8. doi: 10.3109/10428191003715377.

Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy.利妥昔单抗联合化疗治疗 B 细胞淋巴瘤患者中基于 PCR 的诊断方法使肺孢子菌肺炎发生率降低。

Am J Hematol. 2016 Nov;91(11):1113-1117. doi: 10.1002/ajh.24499. Epub 2016 Aug 22.

High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone.接受每两周利妥昔单抗和环磷酰胺、阿霉素、长春新碱和泼尼松治疗的患者中，肺孢子菌肺炎的发病率较高。

Leuk Lymphoma. 2010 May;51(5):797-801. doi: 10.3109/10428191003699860.

Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab.在接受环磷酰胺、多柔比星、长春新碱和泼尼松（CHOP）方案加利妥昔单抗治疗的淋巴瘤患者中出现严重肺部不良反应。

Korean J Intern Med. 2010 Mar;25(1):86-92. doi: 10.3904/kjim.2010.25.1.86. Epub 2010 Feb 26.

引用本文的文献

Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequencing technology.利用宏基因组下一代测序技术，在淋巴瘤患者化疗相关间质性肺炎的支气管肺泡灌洗液中高概率检测到耶氏肺孢子菌。

Infect Agent Cancer. 2023 Dec 6;18(1):80. doi: 10.1186/s13027-023-00556-1.

Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab.利妥昔单抗治疗后低丙种球蛋白血症、迟发性中性粒细胞减少和感染。

Ann Allergy Asthma Immunol. 2023 Jun;130(6):699-712. doi: 10.1016/j.anai.2023.01.018. Epub 2023 Jan 24.

IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.白细胞介素 4 多态性影响 HIV 阳性患者肺孢子菌肺炎的易感性。

AIDS. 2019 Sep 1;33(11):1719-1727. doi: 10.1097/QAD.0000000000002283.

B Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice.清除小鼠肺孢子菌感染时，CD4+ T细胞早期启动阶段需要B淋巴细胞。

J Immunol. 2015 Jul 15;195(2):611-20. doi: 10.4049/jimmunol.1500112. Epub 2015 Jun 3.

Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.接受含利妥昔单抗治疗的淋巴瘤患者中耶氏肺孢子菌肺炎的预防与治疗：一项系统评价和荟萃分析

PLoS One. 2015 Apr 24;10(4):e0122171. doi: 10.1371/journal.pone.0122171. eCollection 2015.

A Systematic Review and Meta-Analysis of Rituximab in Antibody-mediated Renal Allograft Rejection.利妥昔单抗治疗抗体介导的肾移植排斥反应的系统评价和荟萃分析

Int J Organ Transplant Med. 2011;2(2):51-6.

Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma after Rituximab-containing regimen: two cases of report and literature review.利妥昔单抗方案治疗后非霍奇金淋巴瘤患者合并肺孢子菌肺炎：2 例报告并文献复习。

J Thorac Dis. 2013 Aug;5(4):E162-6. doi: 10.3978/j.issn.2072-1439.2013.08.35.

Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?在抗中性粒细胞胞质抗体相关性血管炎中，使用利妥昔单抗治疗时是否应推荐使用预防卡氏肺孢子菌感染？

Clin Rheumatol. 2013 Nov;32(11):1677-81. doi: 10.1007/s10067-013-2293-4. Epub 2013 Jun 11.

Pneumocystis pneumonia in patients treated with rituximab.利妥昔单抗治疗患者中的肺孢子菌肺炎。

Chest. 2013 Jul;144(1):258-265. doi: 10.1378/chest.12-0477.

Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy.根据 R-CHOP 化疗周期数，非霍奇金淋巴瘤患者中卡氏肺孢子虫肺炎的现患率。

Ann Hematol. 2013 Jan;92(2):231-8. doi: 10.1007/s00277-012-1592-1. Epub 2012 Oct 10.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验